JT010

CAS No. 917562-33-5

JT010( —— )

Catalog No. M26725 CAS No. 917562-33-5

JT010 is an effective agonist of TRPA1 (EC50 = 0.65 nM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 50 In Stock
2MG 28 In Stock
5MG 46 In Stock
10MG 73 In Stock
25MG 150 In Stock
50MG 235 In Stock
100MG 351 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    JT010
  • Note
    Research use only, not for human use.
  • Brief Description
    JT010 is an effective agonist of TRPA1 (EC50 = 0.65 nM).
  • Description
    JT010 is an effective agonist of TRPA1 (EC50 = 0.65 nM).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    TRP/TRPV Channel
  • Recptor
    LXRα| LXRβ
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    917562-33-5
  • Formula Weight
    354.85
  • Molecular Formula
    C16H19ClN2O3S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (281.81 mM)
  • SMILES
    COCCCN(C(=O)CCl)c1nc(cs1)-c1ccc(OC)cc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Griffett K, et al. A liver-selective LXR inverse agonist that suppresses hepatic steatosis. ACS Chem Biol. 2013 Mar 15;8(3):559-67.
molnova catalog
related products
  • RQ00203078

    RQ-00203078 is a highly selective, potent and orally available TRPM8 antagonist (IC50 values are 5.3 and 8.3 nM for rat and human channels respectively).

  • LASSBio-1135

    LASSBio-1135 is an orally effective antagonist of TRPV1 and inhibitor of TNF-α production.Oral administration of 100 mol x Kg(-1) LASSBio-1135 markedly reduced thermal hyperalgesia induced by carrageenan.

  • HhAntag

    HhAntag is a small molecule inhibitor of GLI1-mediated transcription, an essential down-stream element of the Hedgehog (Hh) pathway with the anti-tumor activity.